Ryman rights trading ends on a sour note

Ryman rights trading ends on a sour note
Salt Funds' Matt Goodson said time will tell whether Ryman shares are cheap. (Image: Salt Funds)
Jenny Ruth
Ryman Healthcare’s $902 million rights issue is drawing to a dismal close, with the price of the rights falling as low as 7.5 cents on Tuesday, the last day of trading.Two weeks ago, in the institutional book-build auction process, institutional investors were prepared to pay an effective $1 for the rights.You could say that was a little disappointing because the theoretical value of the rights price was $1.03 – institutions paid $6 for the shares issued at $5, so the additional price paid reflected the value they put on the rights....

More Finance

Major corporates disavowing Du Val information memorandum
Finance

Major corporates disavowing Du Val information memorandum

Corporates disavow Du Val IM amid regulatory scrutiny.

Finfluence: why regulators want to fight it
Finance

David Chaplin: Finfluence: why regulators want to fight it

 There is a thin line between the undefined finfluencer boundary.

New funding agency to 'supercharge' social housing
Finance

New funding agency to 'supercharge' social housing

The Community Housing Funding Agency wants to address a $14 billion problem.

Oliver Lewis 25 Nov 2024